Quercetin reduces blood pressure in hypertensive subjects - PubMed (original) (raw)
Randomized Controlled Trial
. 2007 Nov;137(11):2405-11.
doi: 10.1093/jn/137.11.2405.
Affiliations
- PMID: 17951477
- DOI: 10.1093/jn/137.11.2405
Free article
Randomized Controlled Trial
Quercetin reduces blood pressure in hypertensive subjects
Randi L Edwards et al. J Nutr. 2007 Nov.
Free article
Abstract
Epidemiological studies report that quercetin, an antioxidant flavonol found in apples, berries, and onions, is associated with reduced risk of coronary heart disease and stroke. Quercetin supplementation also reduces blood pressure in hypertensive rodents. The efficacy of quercetin supplementation to lower blood pressure in hypertensive humans has never been evaluated. We tested the hypothesis that quercetin supplementation reduces blood pressure in hypertensive patients. We then determined whether the antihypertensive effect of quercetin is associated with reductions in systemic oxidant stress. Men and women with prehypertension (n = 19) and stage 1 hypertension (n = 22) were enrolled in a randomized, double-blind, placebo-controlled, crossover study to test the efficacy of 730 mg quercetin/d for 28 d vs. placebo. Blood pressure (mm Hg, systolic/diastolic) at enrollment was 137 +/- 2/86 +/- 1 in prehypertensives and 148 +/- 2/96 +/- 1 in stage 1 hypertensive subjects. Blood pressure was not altered in prehypertensive patients after quercetin supplementation. In contrast, reductions in (P < 0.01) systolic (-7 +/- 2 mm Hg), diastolic (-5 +/- 2 mm Hg), and mean arterial pressures (-5 +/- 2 mm Hg) were observed in stage 1 hypertensive patients after quercetin treatment. However, indices of oxidant stress measured in the plasma and urine were not affected by quercetin. These data are the first to our knowledge to show that quercetin supplementation reduces blood pressure in hypertensive subjects. Contrary to animal-based studies, there was no quercetin-evoked reduction in systemic markers of oxidative stress.
Similar articles
- Therapeutic potential of quercetin to decrease blood pressure: review of efficacy and mechanisms.
Larson AJ, Symons JD, Jalili T. Larson AJ, et al. Adv Nutr. 2012 Jan;3(1):39-46. doi: 10.3945/an.111.001271. Epub 2012 Jan 5. Adv Nutr. 2012. PMID: 22332099 Free PMC article. Review. - A combination of isolated phytochemicals and botanical extracts lowers diastolic blood pressure in a randomized controlled trial of hypertensive subjects.
Biesinger S, Michaels HA, Quadros AS, Qian Y, Rabovsky AB, Badger RS, Jalili T. Biesinger S, et al. Eur J Clin Nutr. 2016 Jan;70(1):10-6. doi: 10.1038/ejcn.2015.88. Epub 2015 Jun 10. Eur J Clin Nutr. 2016. PMID: 26059745 Clinical Trial. - Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: a randomised double-blinded placebo-controlled cross-over trial.
Brüll V, Burak C, Stoffel-Wagner B, Wolffram S, Nickenig G, Müller C, Langguth P, Alteheld B, Fimmers R, Naaf S, Zimmermann BF, Stehle P, Egert S. Brüll V, et al. Br J Nutr. 2015 Oct 28;114(8):1263-77. doi: 10.1017/S0007114515002950. Epub 2015 Sep 2. Br J Nutr. 2015. PMID: 26328470 Free PMC article. Clinical Trial. - Effects of Potassium Magnesium Citrate Supplementation on 24-Hour Ambulatory Blood Pressure and Oxidative Stress Marker in Prehypertensive and Hypertensive Subjects.
Vongpatanasin W, Peri-Okonny P, Velasco A, Arbique D, Wang Z, Ravikumar P, Adams-Huet B, Moe OW, Pak CYC. Vongpatanasin W, et al. Am J Cardiol. 2016 Sep 15;118(6):849-853. doi: 10.1016/j.amjcard.2016.06.041. Epub 2016 Jun 28. Am J Cardiol. 2016. PMID: 27448942 Free PMC article. Clinical Trial. - Effect of antihypertensive therapy on incident stroke in cohorts with prehypertensive blood pressure levels: a meta-analysis of randomized controlled trials.
Sipahi I, Swaminathan A, Natesan V, Debanne SM, Simon DI, Fang JC. Sipahi I, et al. Stroke. 2012 Feb;43(2):432-40. doi: 10.1161/STROKEAHA.111.636829. Epub 2011 Dec 8. Stroke. 2012. PMID: 22156683 Review.
Cited by
- Association between Dietary Intake, Profibrotic Markers, and Blood Pressure in Patients with Chronic Kidney Disease.
Mohtashamian A, Soleimani A, Gilasi HR, Kheiripour N, Moeini Taba SM, Sharifi N. Mohtashamian A, et al. Adv Biomed Res. 2024 Apr 27;13:29. doi: 10.4103/abr.abr_204_23. eCollection 2024. Adv Biomed Res. 2024. PMID: 39234436 Free PMC article. - Flavonoids: Antioxidant Powerhouses and Their Role in Nanomedicine.
Zahra M, Abrahamse H, George BP. Zahra M, et al. Antioxidants (Basel). 2024 Jul 29;13(8):922. doi: 10.3390/antiox13080922. Antioxidants (Basel). 2024. PMID: 39199168 Free PMC article. Review. - COVID-19-Associated Sepsis: Potential Role of Phytochemicals as Functional Foods and Nutraceuticals.
de Souza Goncalves B, Sangani D, Nayyar A, Puri R, Irtiza M, Nayyar A, Khalyfa A, Sodhi K, Pillai SS. de Souza Goncalves B, et al. Int J Mol Sci. 2024 Aug 3;25(15):8481. doi: 10.3390/ijms25158481. Int J Mol Sci. 2024. PMID: 39126050 Free PMC article. Review. - Phytonutrients in the promotion of healthspan: a new perspective.
Jacquier EF, Kassis A, Marcu D, Contractor N, Hong J, Hu C, Kuehn M, Lenderink C, Rajgopal A. Jacquier EF, et al. Front Nutr. 2024 Jul 12;11:1409339. doi: 10.3389/fnut.2024.1409339. eCollection 2024. Front Nutr. 2024. PMID: 39070259 Free PMC article. Review. - Contemporary Insights into the Biological Mechanisms of Parkia biglobosa.
Komolafe K, Olaleye MT, Huang HC, Pacurari M. Komolafe K, et al. Int J Environ Res Public Health. 2024 Mar 24;21(4):394. doi: 10.3390/ijerph21040394. Int J Environ Res Public Health. 2024. PMID: 38673307 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical